StockData
Zentalis Pharmaceuticals, Inc. logo

Zentalis Pharmaceuticals, Inc. (ZNTL) stock

ZNTLNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 6/30
$1.36+0.00 (0.00%)

Close on Nov 19, 2026Market cap $97.47MP/E –Yield –

Earnings

Zentalis Pharmaceuticals's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
Mar 25, 2027
Q4 FY2026 · estimated, after the close
Revenue, Q3 FY2026
–
EPS, Q3 FY2026
-$0.34
-$0.37 a year earlier
Latest guidance
None
No outlook given in releases

Quarterly results

Revenue and earnings per share from each of Zentalis Pharmaceuticals's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource
Q4 FY2026ended Dec 31, 2026Mar 25, 2027Expected––––
Q3 FY2026ended Sep 30, 2026Nov 9, 2026after the close––-$0.34Release
Q2 FY2026ended Jun 30, 2026Aug 6, 2026after the close–––Release
Q1 FY2026ended Mar 31, 2026May 12, 2026after the close––-$0.50Release
Q4 FY2025ended Dec 31, 2025Mar 26, 2026after the close–––Release
Q3 FY2025ended Sep 30, 2025Nov 10, 2025after the close––-$0.37Release
Q2 FY2025ended Jun 30, 2025Aug 6, 2025after the close––-$0.37Release
Q1 FY2025ended Mar 31, 2025May 14, 2025after the close––-$0.67Release
Q4 FY2024ended Dec 31, 2024Mar 26, 2025after the close–––Release
Q2 FY2024ended Jun 30, 2024Aug 9, 2024before the open––-$1.24Release
Q1 FY2024ended Mar 31, 2024May 7, 2024before the open$40.56M–$0.14Release
Q4 FY2023ended Dec 31, 2023Feb 27, 2024before the open–––Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Guidance

Zentalis Pharmaceuticals has not given guidance in its releases

Many companies give their outlook only on the conference call or not at all. When Zentalis Pharmaceuticals puts a forecast in an earnings release, it is listed here with the exact sentence.

Press releases

Releases Zentalis Pharmaceuticals filed with the SEC as exhibits to Form 8-K or 6-K

  1. Results
  2. Results
  3. Results
  4. Results
  5. Update
  6. Results
  7. Results
  8. Update
  9. Update
  10. Update
  11. Update
  12. Update
  13. Update
  14. Results
  15. Update

See a number that looks wrong?